Top Medicated Eye Treatments for Horses in the UK: 2026 Guide

Fucithalmic Vet (fusidic acid) is positioned as a cost-effective, targeted topical antibiotic for equine bacterial conjunctivitis and superficial infections, offering strong Gram‑positive coverage and good ocular tissue penetration in horses. Compared with broad‑spectrum ointments or steroid combinations on this list, it provides a lower-risk option when inflammation is not severe and avoids the regulatory and performance-doping complexities of steroid-containing products. Its financial advantage is predictable low cost and typically shorter treatment courses when used against susceptible organisms, making it a practical first-line for many equine practices.

Isathal Eye Drops is presented as a veterinary topical antibacterial formulated for equine use with balanced aqueous dispersion for good corneal contact, offering an affordable liquid alternative to ointments when frequent dosing is practical. Technically it can reach deeper pockets of the conjunctival sac more readily than greasy ointments, making it useful for large or difficult-to-keep-open equine eyes; financially it often undercuts newer fluoroquinolone preparations while providing reliable coverage for common pathogens. Compared to gels like Remend or steroid/antibiotic combos such as Maxitrol, Isathal is best used as a straightforward antimicrobial rather than a repair or anti-inflammatory agent.

Maxitrol combines a potent topical steroid with broad-spectrum antibiotics, offering fast symptomatic relief and infection control in inflammatory equine ocular conditions where inflammation is causing significant discomfort or scarring risk. Its technical advantage is rapid suppression of inflammation compared with purely antibacterial products like Fucithalmic or chloramphenicol, but this brings higher risk if used on unrecognized corneal ulcers and typically higher regulatory scrutiny and cost. In equine practice Maxitrol is therefore valued for acute inflammatory control but used more cautiously and often as a short-term or adjunctive therapy relative to non-steroidal options.

Remend Corneal Repair Gel is a non‑antibiotic hydrogel designed to support corneal epithelial healing and provide long‑lasting lubrication in horses, making it uniquely suited as an adjunct to antimicrobial therapy rather than a primary infection control agent. Its technical strength lies in promoting re-epithelialization and protecting the corneal surface, which can reduce overall treatment time and lower cumulative antibiotic use when paired with agents such as Fucithalmic or chloramphenicol. Financially, using a repair gel can be cost‑effective by shortening healing periods and reducing repeat veterinary interventions compared with relying on antibiotics alone.

Opticlox (a topical fluoroquinolone formulation) is positioned as a high‑potency, broad‑spectrum option for equine bacterial keratitis with strong Gram‑negative activity and excellent corneal penetration, making it a go-to for more serious or mixed infections. Technically superior for resistant or deep corneal infections compared with older agents like chloramphenicol or dibromopropamidine, it typically commands a higher price but can reduce overall treatment duration and the need for multiple agents. In practice it is often reserved for cases where first‑line, less expensive antibiotics have failed or where cytological/ culture data suggest fluoroquinolone sensitivity.

Veterinary chloramphenicol 1% ointment is a widely used, affordable broad‑spectrum antibiotic for equine ocular infections with good corneal penetration and a long track record in field use. Its primary advantage over more expensive fluoroquinolones or steroid combinations is cost and availability, making it a default empiric choice for many practitioners; however, it lacks the anti‑inflammatory benefits of steroid combos like Maxitrol and the specialized healing promotion of gels like Remend. For many horse owners and vets, chloramphenicol offers a pragmatic balance of efficacy and economy for uncomplicated bacterial conjunctivitis and superficial keratitis.